News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

By studying biosamples collected from participants in RECOVER’s pediatric observational study, researchers can better understand the biological mechanisms, or changes in the body, associated with Long COVID.
The next phase of RECOVER’s pathobiology studies will focus on discoveries that can more immediately inform efforts to diagnose, prevent, and treat Long COVID.
RECOVER researchers continue to publish findings that could help scientists, doctors, patients, and caregivers navigate the complexities of Long COVID.
Biosamples collected during RECOVER clinical trials can provide valuable information about how people’s bodies respond to treatment. Researchers who receive funding through a new research opportunity can now access these samples.
In 2026 so far, RECOVER has published new research findings across nearly all its different studies and will soon be enrolling participants for the next phases of the adult observational study and clinical trials.
Findings from this RECOVER pathobiology study may guide future efforts to treat Long COVID-related thinking problems and fatigue.
RECOVER scientists, study participants, and Representatives are working together to make new discoveries about Long COVID and how to diagnose, prevent, and treat its symptoms.
As RECOVER’s adult observational study moves to the next phase, researchers continue to explore the various causes of common Long COVID symptoms, such as difficulty breathing.